Cancer Research 101: Tobacco Company Profits are OBSCENE

Cancer Research 101

A blog that explains some of the astounding progress, promise and some real caveats behind the headlines of today's (and tomorrow's) cancer research. It is written for the NON-scientist by Dr Michael Wosnick, a recently retired senior cancer research executive, who has over 20 years of experience in the field and who has a penchant for cancer research but also a demonstrated talent for explaining technical and complex science in a way that anyone can understand and appreciate.

Tuesday, March 27, 2012

Tobacco Company Profits are OBSCENE

The World Lung Foundation and the American Cancer Society have teamed up to produce the 4th edition of what they call the "Tobacco Atlas". It was released last week in Singapore.

The website of the Tobacco Atlas is a sobering stop for anyone who thinks that it is nothing short of insanity to continue to allow big tobacco to produce a product whose sole aim, aside from raking in Billions in profits ($35B estimated annual global PROFIT) is to continue to addict people, and, when used as intended, to hugely increase the probability of death and kill its own customers (at the rate of at least 6 Million deaths annually).

Here is a copy of the Press Release (in embedded PDF format - use the zoom in/out control to better view) from the Atlas launch that summarizes the report.

If ever you felt motivated to use your voices to effect some good, you could not pick a more worthy cause...

Tobacco Atlas Press Release March 21, 2012

Labels: health policy, lung cancer deaths, public engagement, tobacco

0 Comments:

Post a Comment

A major purpose of this Blog is to encourage discussion, debate and thoughtful exchange. Please feel free to comment, or ask a question...

Subscribe to Post Comments [Atom]

<< Home

About Me

Name: Dr. Michael A. Wosnick

Location: Richmond Hill, Ontario, Canada

As the first VP, Research of the Canadian Cancer Society (CCS) and Scientific Director of the CCS Research Institute, I had oversight of all of the Society’s research programs across the country: a cancer research portfolio of between $40 and $50 Million annually. Prior to these appointments I served the National Cancer Institute of Canada (NCIC) in two successive capacities – as Executive Director for 7 years, and prior to that as Director of Research Programs for more than 10 years. In total, I have almost 35 years of experience encompassing the academic, biotechnology and not-for-profit sectors. Prior to the NCIC, I worked at Allelix Biopharmaceuticals Inc. in Toronto in various senior research capacities, and was a Research Scientist and Group Leader at Toronto's Connaught Research Institute. I hold a B.Sc. degree from the University of Toronto (1974), and a Ph.D. degree in molecular biology from Queen's University in Kingston, Ontario (1978). I did further training as a Post-Doctoral Fellow of the Medical Research Council of Canada, working in the fields of molecular biology and gene expression at the University of Calgary Medical School (1978 through 1981).

This Page